Sirona Biochem Corp. (ZSB.F)
- Previous Close
0.0400 - Open
0.0430 - Bid 0.0365 x 2500000
- Ask 0.0485 x 3000000
- Day's Range
0.0430 - 0.0430 - 52 Week Range
0.0394 - 0.1070 - Volume
19,494 - Avg. Volume
9,601 - Market Cap (intraday)
13.088M - Beta (5Y Monthly) -0.44
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Jun 27, 2024 - Jul 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
www.sironabiochem.comRecent News: ZSB.F
Performance Overview: ZSB.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZSB.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZSB.F
Valuation Measures
Market Cap
12.18M
Enterprise Value
13.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
407.66
Price/Book (mrq)
--
Enterprise Value/Revenue
376.85
Enterprise Value/EBITDA
-5.76
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-201.51%
Return on Equity (ttm)
--
Revenue (ttm)
36.35k
Net Income Avi to Common (ttm)
-2.65M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
112.98k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.02M
Company Insights: ZSB.F
ZSB.F does not have Company Insights